Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice

  • Valeria Cento
  • , Monica Tontodonati
  • , Velia Chiara Di Maio
  • , Maria Concetta Bellocchi
  • , Fabrizio Valenti
  • , Alessandra Manunta
  • , Serena Fortuna
  • , Daniele Armenia
  • , Luca Carioti
  • , Francesco Paolo Antonucci
  • , Ada Bertoli
  • , Francesca Trave
  • , Pierluigi Cacciatore
  • , Mario Angelico
  • , Pierluigi Navarra
  • , Avidan U. Neumann
  • , Jacopo Vecchiet
  • , Giustino Parruti
  • , Sergio Babudieri
  • , Carlo Federico Perno
  • Francesca Ceccherini-Silberstein

Risultato della ricerca: Contributo in rivistaArticolo

4 Citazioni (Scopus)

Abstract

The used first generation protease inhibitors may be hampered by virological failure in partially interferon-sensitive patients.
Lingua originaleInglese
pagine (da-a)233-241
Numero di pagine9
RivistaDigestive and Liver Disease
Volume47
DOI
Stato di pubblicazionePubblicato - 2015

Keywords

  • Aged
  • Antiviral Agents
  • Drug Resistance, Viral
  • Drug Therapy, Combination
  • Drug-resistance
  • Female
  • Genotype
  • Hepacivirus
  • Hepatitis C, Chronic
  • Humans
  • Interferon-alpha
  • Linear Models
  • Male
  • Mathematical modelling
  • Middle Aged
  • Mutation
  • Oligopeptides
  • Protease Inhibitors
  • Protease inhibitors
  • RNA Stability
  • RNA, Viral
  • Ribavirin
  • Treatment Outcome
  • Viral Load
  • Viral kinetic
  • Virus Replication

Fingerprint

Entra nei temi di ricerca di 'Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice'. Insieme formano una fingerprint unica.

Cita questo